NASDAQ:GLMD
Galmed Pharmaceuticals Ltd.
- Stock
locale
Israelmarket
STOCKSindustry
Biotechnologywebsite
www.galmedpharma.comipo date
Mar 13, 2014
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The com...Show More
Earnings
Earnings Release in 11 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus